Inhibition of NADPH oxidase improves impaired reactivity of pial arterioles during chronic exposure to nicotine.
about
Nitroxide pharmaceutical development for age-related degeneration and diseaseNeuronal nitric oxide mediates cerebral vasodilatation during acute hypertensionCigarette smoke and inflammation: role in cerebral aneurysm formation and rupture.Nitric oxide synthase-dependent responses of the basilar artery during acute infusion of nicotineNox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain.Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia.Tempol improves cutaneous thermal hyperemia through increasing nitric oxide bioavailability in young smokers.Exercise training restores impaired dilator responses of cerebral arterioles during chronic exposure to nicotine.The role of oxidative stress and NADPH oxidase in cerebrovascular disease.Prenatal nicotine increases matrix metalloproteinase 2 (MMP-2) expression in fetal guinea pig heartsMicrovascular Dysfunction and Cognitive Impairment.NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for Prevention.Nicotine and vascular endothelial dysfunction in female ovariectomized rats: role of estrogen replacement therapy.Effect of agmatine on experimental vascular endothelial dysfunction.Rho-kinase inhibitor and nicotinamide adenine dinucleotide phosphate oxidase inhibitor prevent impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats.Acute infusion of nicotine impairs nNOS-dependent reactivity of cerebral arterioles via an increase in oxidative stress.Tetrahydrobiopterin rescues impaired responses of cerebral resistance arterioles during type 1 diabetes.Chronic nicotine exposure exacerbates transient focal cerebral ischemia-induced brain injury.
P2860
Q26776523-0215AB54-1DD1-4264-879E-51A28235C0C1Q28580302-313F92B6-565A-4DC8-B09E-572690BD4B87Q30422894-DB4BFDF7-F426-4A5C-8E94-1C9D8261CF48Q30486865-2C0B29CD-1A85-46AF-85A6-7CADE35249DDQ33281864-567C8FA4-B24E-4CC1-BFC1-29F7AA7CE8EDQ33357269-28628D03-7F54-4E69-A159-17A6273196CBQ33701950-F388E2D0-0631-438C-BA8D-93E2527FF59CQ34236360-A8779675-DBE8-46C0-B737-919C06F11D35Q35118380-19F3B485-458F-4348-BAA3-3CF7E9930D21Q35931128-3A3BDD81-C535-44D6-8A3F-A0438A13DE9EQ36839870-6E1DDF07-FBED-4472-9CFF-7F10D21096FDQ37081593-92F73998-0B7F-4320-A7B8-8A06867E34FBQ46224035-007508F1-0767-4913-93DC-313021104ED8Q46255885-D36C5BE0-C458-4CF5-AA56-0B59D0FD6CD6Q46515331-0A22D4AB-FDF1-4798-834B-65586F7F2A5EQ46977317-5413CEFA-5AE6-4E60-BD06-EC2B78D1E2E9Q48399202-3A6B497A-B130-418A-BCD0-0CCCA1C69502Q49156234-44859EFB-7E38-4CA2-9232-EF42EDCF6CE9
P2860
Inhibition of NADPH oxidase improves impaired reactivity of pial arterioles during chronic exposure to nicotine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibition of NADPH oxidase im ...... chronic exposure to nicotine.
@en
Inhibition of NADPH oxidase im ...... chronic exposure to nicotine.
@nl
type
label
Inhibition of NADPH oxidase im ...... chronic exposure to nicotine.
@en
Inhibition of NADPH oxidase im ...... chronic exposure to nicotine.
@nl
prefLabel
Inhibition of NADPH oxidase im ...... chronic exposure to nicotine.
@en
Inhibition of NADPH oxidase im ...... chronic exposure to nicotine.
@nl
P2093
P2860
P1476
Inhibition of NADPH oxidase im ...... chronic exposure to nicotine.
@en
P2093
Denise M Arrick
William G Mayhan
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00975.2005
P407
P577
2005-10-06T00:00:00Z